Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | PARP1 | P09874 | 2/20 | 0.40 |
| ▸ | MRGPRX4 | Q96LA9 | 2/20 | 0.39 |
| ▸ | PTGES | O14684 | 9/20 | 0.38 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ABL1 | P00519 | 1/20 | 0.37 |
| ▸ | SRC | P12931 | 1/20 | 0.37 |
| ▸ | DHODH | Q02127 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6489411 | 0.87 | DHODH (0.46) | KDM4EALDH1A1LMNAHPGDPARP1 | |
| SCHEMBL6491011 | 0.84 | PRMT5 (0.43) | KDM4EALDH1A1LMNAHTTHPGD | |
| SCHEMBL6501625 | 0.84 | PTGES (0.40) | KDM4EALDH1A1LMNAHTTHPGD | |
| SCHEMBL6499860 | 0.82 | PRMT5 (0.47) | LMNAHTT | |
| SCHEMBL7197499 | 0.76 | DHODH (0.55) | PARP1DHODH | |
| SCHEMBL6498657 | 0.75 | ALDH1A1 (0.40) | KDM4EALDH1A1LMNAHTTL3MBTL1 | |
| Hydrochloric Acid SCHEMBL6492977 | 0.70 | ALDH1A1 (0.46) | KDM4EALDH1A1LMNAHTTHPGD | |
| SCHEMBL31123658 | 0.69 | ALDH1A1 (0.60) | KDM4EALDH1A1LMNAHPGDHIF1A | |
| SCHEMBL15286510 | 0.68 | ALDH1A1 (0.51) | KDM4EALDH1A1LMNAL3MBTL1HPGD | |
| SCHEMBL23512330 | 0.68 | KDM4E (0.51) | KDM4EALDH1A1LMNAHTTL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050014812-A1 | Benzimidazole compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2005-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014812-A1 | Benzimidazole compounds | SLC5A1, SLC5A2, G6PD | KDM4E 760/4885ALDH1A1 96/4885LMNA 3711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.